Oseltamivir (Tamiflu®) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans – a review
The antiviral drug oseltamivir (Tamiflu®) is a cornerstone in influenza pandemic preparedness plans worldwide. However, resistance to the drug is a growing concern. The active metabolite oseltamivir carboxylate (OC) is not degraded in surface water or sewage treatment plants and has been...
Main Author: | Josef D. Järhult |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2012-06-01
|
Series: | Infection Ecology & Epidemiology |
Subjects: | |
Online Access: | http://www.infectionecologyandepidemiology.net/index.php/iee/article/view/18385/pdf_1 |
Similar Items
-
The qualitative determination of oseltamivir phosphate in Tamiflu® capsule by cyclic voltammetry
by: Avramov-Ivić Milka L., et al.
Published: (2011-01-01) -
Assay to Detect Oseltamivir Resistance
by: Kamol Suwannakarn, et al.
Published: (2006-12-01) -
Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
by: Renee W. Y. Chan, et al.
Published: (2022-02-01) -
Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs’ excretion into the bile and kidney
by: Kunio Fujiwara, et al.
Published: (2020-06-01) -
Oseltamivir (Tamiflu)-induced bilateral ciliochoroidal effusion and angle closure glaucoma: What type of idiosyncratic reaction?
by: Shahin Yazdani, et al.
Published: (2017-01-01)